Tracy Newbold

Directeur Technique/Scientifique/R&D chez LEXICON PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Postes actifs de Tracy Newbold

Sociétés	Poste	Début	Fin
LEXICON PHARMACEUTICALS, INC.	Directeur Technique/Scientifique/R&D	01/07/2021	-

Sociétés	Poste	Début	Fin
Atox Bio Ltd. Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel.	Corporate Officer/Principal	01/01/2017	01/01/2020
UNITED THERAPEUTICS CORPORATION	Directeur des opérations	01/01/2011	01/01/2017
IMMUNOVANT, INC.	Directeur Technique/Scientifique/R&D	01/02/2020	-

The University of North Carolina at Chapel Hill

Undergraduate Degree

Internationale

Etats-Unis	5
Israël	2

Opérationnelle

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	1
Chief Operating Officer	1

Sectorielle

Health Technology	5
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	3
IMMUNOVANT, INC.	Health Technology
UNITED THERAPEUTICS CORPORATION	Health Technology
LEXICON PHARMACEUTICALS, INC.	Health Technology

Entreprise privées	1
Atox Bio Ltd. Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel.	Health Technology

Entreprise privées

Health Technology